These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7871267)
1. [Etiopathogenesis of non-insulin-dependent diabetes]. Blicklé JF; Robillart I; Brogard JM Rev Med Interne; 1995; 16(1):20-30. PubMed ID: 7871267 [TBL] [Abstract][Full Text] [Related]
2. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome]. Hrnciar J Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027 [TBL] [Abstract][Full Text] [Related]
3. A review of new developments in type 2 diabetes in human beings and cats. Lutz TA; Rand JS Br Vet J; 1993; 149(6):527-36. PubMed ID: 8111613 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion. Groop L Int J Clin Pract Suppl; 2000 Oct; (113):3-13. PubMed ID: 11965829 [TBL] [Abstract][Full Text] [Related]
5. [And what about diabetes?]. Cerasi E Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448 [TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of type II diabetes mellitus. A polygenic disease. Sacks DB; McDonald JM Am J Clin Pathol; 1996 Feb; 105(2):149-56. PubMed ID: 8607437 [TBL] [Abstract][Full Text] [Related]
7. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes. Ludvik B; Lell B; Hartter E; Schnack C; Prager R Diabetes; 1991 Dec; 40(12):1615-9. PubMed ID: 1756902 [TBL] [Abstract][Full Text] [Related]
8. Insulin resistance as the core defect in type 2 diabetes mellitus. Goldstein BJ Am J Cardiol; 2002 Sep; 90(5A):3G-10G. PubMed ID: 12231073 [TBL] [Abstract][Full Text] [Related]
10. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. Beck-Nielsen H; Groop LC J Clin Invest; 1994 Nov; 94(5):1714-21. PubMed ID: 7962519 [No Abstract] [Full Text] [Related]
11. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance]. Ludvik B Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227 [TBL] [Abstract][Full Text] [Related]
12. [Physiopathology of non-insulin-dependent diabetes: current data and therapeutic consequences]. Broussolle C; Orgiazzi J; Noël G Rev Med Interne; 1990; 11(2):142-8. PubMed ID: 2204978 [TBL] [Abstract][Full Text] [Related]
14. [Glucotoxicity and lipotoxicity: factors in the pathogenesis and evolution of type 2 diabetes]. Durruty P; García de los Ríos M Rev Med Chil; 2001 Jun; 129(6):671-9. PubMed ID: 11510210 [TBL] [Abstract][Full Text] [Related]
15. Amylin and diabetes. Amiel S Lancet; 1993 May; 341(8855):1249-50. PubMed ID: 8098399 [No Abstract] [Full Text] [Related]
16. Unraveling the causes of diabetes. Marx J Science; 2002 Apr; 296(5568):686-9. PubMed ID: 11976439 [No Abstract] [Full Text] [Related]
17. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Cooper GJ; Leighton B; Dimitriadis GD; Parry-Billings M; Kowalchuk JM; Howland K; Rothbard JB; Willis AC; Reid KB Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7763-6. PubMed ID: 3051005 [TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. Kruszynska YT; Olefsky JM J Investig Med; 1996 Oct; 44(8):413-28. PubMed ID: 8952222 [No Abstract] [Full Text] [Related]
19. [From the natural history of non-insulin-dependent diabetes and its etiopathogenesis]. Brogard JM; Robillart I Rev Med Interne; 1994; 15 Suppl 3():266S-269S. PubMed ID: 7863130 [No Abstract] [Full Text] [Related]
20. [Etiopathogenesis and pathophysiology of type 2 diabetes]. Féry F; Paquot N Rev Med Liege; 2005; 60(5-6):361-8. PubMed ID: 16035295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]